Asia Green Biotechnology (XCNQ:ASIA) Total Operating Expense: C$0.30 Mil (TTM As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Asia Green Biotechnology Total Operating Expense?

Asia Green Biotechnology XCNQ:ASIA Total Operating Expense is C$0.30 Mil as of Sep. 2024.

Asia Green Biotechnology's Total Operating Expense for the three months ended in Sep. 2024 was C$0.04 Mil. Asia Green Biotechnology's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.30 Mil.

Asia Green Biotechnology Total Operating Expense Related Terms

Asia Green Biotechnology Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Asia Green Biotechnology's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asia Green Biotechnology Total Operating Expense Chart

Asia Green Biotechnology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial 0.73 0.55 0.52 0.18 0.17

Asia Green Biotechnology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.12 0.04 0.10 0.04

Asia Green Biotechnology Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of C$0.30 Mil mean?
Asia Green Biotechnology (XCNQ:ASIA) has a Total Operating Expense of C$0.30 Mil as of Sep. 2024. Total operating expense is the primary recurring expense associated with central operations. View historical data on Asia Green Biotechnology and its competitors.
Is Asia Green Biotechnology's Total Operating Expense too high?
Asia Green Biotechnology's current Total Operating Expense is C$0.30 Mil.
How does Asia Green Biotechnology's Total Operating Expense compare to ZTS?
Asia Green Biotechnology's Total Operating Expense of C$0.30 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Asia Green Biotechnology and its competitors. Asia Green Biotechnology's current Total Operating Expense is C$0.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asia Green Biotechnology stock overvalued right now?
Asia Green Biotechnology (XCNQ:ASIA) has a current Total Operating Expense of C$0.30 Mil. The current Total Operating Expense is C$0.30 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Asia Green Biotechnology (XCNQ:ASIA), the current Total Operating Expense is C$0.30 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asia Green Biotechnology Business Description

Address 707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.